๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

High dose methotrexate as a preoperative adjuvant in the treatment of epidermoid carcinoma of the head and neck: A feasibility study and clinical trial

โœ Scribed by John L. Tarpley; Paul B. Chretien; John C. Alexander Jr; Robert C. Hoye; Jerome B. Block; Alfred S. Ketcham


Book ID
115691741
Publisher
Elsevier Science
Year
1975
Tongue
English
Weight
575 KB
Volume
130
Category
Article
ISSN
0002-9610

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Thirty-six-hour preoperative high-dose m
โœ Hande, K. R. ;Chretien, P. B. ;Elias, E. G. ;Goldberg, N. H. ;Brooks, A. E. ;Cha ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 330 KB

Twenty 36-hour infusions of high-dose methotrexate were given preoperatively to 10 patients with head and neck cancer. Plasma methotrexate levels of greater than 1 X 10(-5) M were maintained for 36 hours and declined with primary and secondary plasma half-lives of 1.7 and 9.2 hours following the end

Methotrexate content in squamous cell ca
โœ Schifeling, David J. ;George, Todd ;McGuirt, Fred ;Capizzi, Robert L. ;Kamen, Ba ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 232 KB

## Abstract Eleven patients with squamous carcinoma of the head and neck who were scheduled for surgical resection or endoscopic biopsy of tumor received 15 mg/m^2^ of methotrexate (MTX). Samples of tumor, normal mucosa, and plasma were obtained at surgery or endoscopy, 18โ€24 hours after the last M